Tempest Therapeutics, Inc. Operating Leases, Rent Expense
Tempest Therapeutics, Inc. (TPST) reported Operating Leases, Rent Expense of $800.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2018-03-15
- Tempest Therapeutics, Inc. operating leases, rent expense for fiscal 2017 was $800.00K, a 0.00% change from fiscal 2016.
- Tempest Therapeutics, Inc. operating leases, rent expense for fiscal 2016 was $800.00K, a 11.11% decline from fiscal 2015.
- Tempest Therapeutics, Inc. operating leases, rent expense for fiscal 2015 was $900.00K, a 50.00% increase from fiscal 2014.
- Tempest Therapeutics, Inc. operating leases, rent expense for fiscal 2014 was $600.00K, a 50.00% increase from fiscal 2013.
| Period end | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed | Operating Leases, Rent Expense 21 month | Operating Leases, Rent Expense 33 month |
|---|---|---|---|---|---|
| 2017-12-31 | $800.00K 10-K · filed 2018-03-15 | ||||
| 2016-12-31 | $800.00K 10-K · filed 2018-03-15 | ||||
| 2015-12-31 | $900.00K 10-K · filed 2018-03-15 | ||||
| 2014-12-31 | $600.00K 10-K · filed 2017-03-02 | ||||
| 2013-12-31 | $400.00K 10-K · filed 2016-02-26 | $600.00K 10-K · filed 2014-02-27 | |||
| 2012-12-31 | $200.00K 10-K · filed 2015-03-16 | $176.00K 10-K · filed 2013-02-25 | $217.00K 10-K · filed 2013-02-25 | ||
| 2011-12-31 | $41.00K 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |